Loading patent…
AssigneeInBios International, Inc.
InventorsJames William NEEDHAM, Syamal RAYCHAUDHURI
Estimating the term…
The present invention relates to compositions and methods involving diagnostic tests with multiple test antigens. The present invention involves the expanded use of test antigens as cross-reactive control antigens (CCAs). The invention advantageously provides for enhanced test results analysis by simultaneously providing both test antigen and CCA signal results. These results, in turn, allow useful sample comparison and cross-reference between samples to more accurately identify and verify the fidelity of test results obtained for multiple infective agents at once. The present invention may include compositions and methods for detecting infection by Zika virus or another flavivirus, and may distinguish between infections caused by genetically similar agents.
A diagnostic assay comprising two or more different test antigens, wherein each test antigen binds to each of a common bound component and a common test antigen conjugate;
(canceled)
(canceled)
The kit of claim 16, wherein the kit comprises anti-IgM antibodies, normal cell antigen, a negative control sample, a positive control sample, a detecting agent, and buffers, and wherein the anti-IgM antibodies, normal cell antigen, negative control sample, positive control sample, detecting agent, and buffers for use with each of the different test antigens are the same.
A method for distinguishing between related infective agents in vitro comprising:
(canceled)
(canceled)
Dependencies are inferred from the claim text.